In vivo and in vitro postovulatory aging: when time works against oocyte quality?

J Assist Reprod Genet. 2022 Apr;39(4):905-918. doi: 10.1007/s10815-022-02418-y. Epub 2022 Mar 21.

Abstract

In mammalian species an optimal fertilization window during which successful fertilization occurs. In the majority of mammals estrus marks ovulation time and coincident with mating, thereby allowing the synchronized meeting in the fallopian tubes, between freshly ejaculated sperm and freshly ovulated oocytes. Conversely, women do not show natural visual signs of ovulation such that fertilization can occur hours later involving an aged oocyte and freshly ejaculated spermatozoa. During this time, the oocyte undergoes a rapid degradation known as "postovulatory aging" (POA). POA may become particularly important in the human-assisted reproductive technologies, as the fertilization of retrieved mature oocytes can be delayed due to increased laboratory workload or because of unforeseeable circumstances, like the delayed availability of semen samples. This paper is an updated review of the consequences of POA, either in vivo or in vitro, on oocyte quality with particular attention to modifications caused by POA on oocyte nuclear, cytoplasmic, genomic, and epigenetic maturation, and embryo development.

Keywords: Antiaging chemicals; Assisted reproductive technology; Morphological alteration; Oocyte; Oxidative stress; Postovulatory aging.

Publication types

  • Review

MeSH terms

  • Aged
  • Aging / genetics
  • Animals
  • Cellular Senescence*
  • Embryonic Development
  • Female
  • Humans
  • Male
  • Mammals
  • Oocytes*
  • Ovulation